ResMed Inc Reports Change in Beneficial Ownership

Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh ( (AU:RMD) ) has provided an update.

ResMed Inc has reported a change in beneficial ownership as per a transaction conducted under a Rule 10b5-1 plan. Peter C. Farrell, the Chairman Emeritus, disposed of 2,000 shares of ResMed common stock at a price of $247.32 per share, leaving him with a total of 69,218 shares. This transaction reflects ongoing strategic financial management within the company and may have implications for stakeholders regarding the company’s stock performance and executive shareholding patterns.

The most recent analyst rating on (AU:RMD) stock is a Buy with a A$33.70 price target. To see the full list of analyst forecasts on Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh stock, see the AU:RMD Stock Forecast page.

More about Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh

ResMed Inc is a company operating in the healthcare industry, primarily focusing on the development and manufacturing of equipment related to sleep disorders, such as sleep apnea, and other respiratory conditions. The company is known for its innovative solutions in sleep and respiratory care, catering to a global market.

Average Trading Volume: 1,271,895

Technical Sentiment Signal: Strong Buy

Current Market Cap: A$56.78B

For an in-depth examination of RMD stock, go to TipRanks’ Stock Analysis page.